CLB logo

Core Laboratories NV (CLB) EBITDA

Annual EBITDA

$73.51 M
+$3.08 M+4.38%

December 31, 2024


Summary


Performance

CLB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLBprofitabilitymetrics:

Quarterly EBITDA

$17.84 M
-$5.64 M-24.03%

December 31, 2024


Summary


Performance

CLB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLBprofitabilitymetrics:

TTM EBITDA

$73.51 M
-$617.00 K-0.83%

December 31, 2024


Summary


Performance

CLB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLBprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CLB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.4%-3.3%+4.4%
3 y3 years+15.3%-3.3%+4.4%
5 y5 years-38.4%-3.3%+4.4%

CLB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+25.3%-24.0%+328.2%-0.8%+47.3%
5 y5-year-38.4%+231.4%-36.8%+117.2%-38.4%+227.6%
alltimeall time-80.3%+231.4%-81.7%+117.2%-80.3%+227.6%

Core Laboratories NV EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$73.51 M(+4.4%)
$17.84 M(-24.0%)
$73.51 M(-0.8%)
Sep 2024
-
$23.48 M(+18.7%)
$74.13 M(+7.0%)
Jun 2024
-
$19.78 M(+59.3%)
$69.25 M(-4.2%)
Mar 2024
-
$12.41 M(-32.7%)
$72.31 M(+2.7%)
Dec 2023
$70.42 M(+20.0%)
$18.45 M(-0.8%)
$70.42 M(-1.7%)
Sep 2023
-
$18.60 M(-18.6%)
$71.66 M(-0.3%)
Jun 2023
-
$22.84 M(+117.0%)
$71.88 M(+10.5%)
Mar 2023
-
$10.53 M(-46.5%)
$65.04 M(+10.8%)
Dec 2022
$58.69 M(-8.0%)
$19.69 M(+4.7%)
$58.69 M(+1.9%)
Sep 2022
-
$18.82 M(+17.5%)
$57.59 M(+15.4%)
Jun 2022
-
$16.01 M(+284.3%)
$49.91 M(-3.0%)
Mar 2022
-
$4.17 M(-77.6%)
$51.45 M(-19.3%)
Dec 2021
$63.78 M(-214.0%)
$18.60 M(+67.0%)
$63.78 M(-13.1%)
Sep 2021
-
$11.14 M(-36.6%)
$73.42 M(-6.8%)
Jun 2021
-
$17.55 M(+6.4%)
$78.78 M(+22.9%)
Mar 2021
-
$16.49 M(-41.6%)
$64.09 M(-214.6%)
Dec 2020
-$55.94 M(-146.9%)
$28.24 M(+71.2%)
-$55.94 M(-2.9%)
Sep 2020
-
$16.50 M(+477.2%)
-$57.59 M(+54.9%)
Jun 2020
-
$2.86 M(-102.8%)
-$37.18 M(+495.5%)
Mar 2020
-
-$103.53 M(-489.4%)
-$6.24 M(-105.2%)
Dec 2019
$119.29 M(-15.8%)
$26.59 M(-27.9%)
$119.29 M(+2.5%)
Sep 2019
-
$36.90 M(+9.2%)
$116.40 M(-3.0%)
Jun 2019
-
$33.79 M(+53.6%)
$120.05 M(-4.4%)
Mar 2019
-
$22.00 M(-7.2%)
$125.58 M(-11.4%)
Dec 2018
$141.71 M(+5.4%)
$23.70 M(-41.6%)
$141.71 M(-9.4%)
Sep 2018
-
$40.56 M(+3.2%)
$156.45 M(+5.3%)
Jun 2018
-
$39.32 M(+3.1%)
$148.56 M(+4.0%)
Mar 2018
-
$38.13 M(-0.8%)
$142.78 M(+6.2%)
Dec 2017
$134.49 M(+17.6%)
$38.44 M(+17.7%)
$134.49 M(+7.3%)
Sep 2017
-
$32.66 M(-2.6%)
$125.39 M(+3.7%)
Jun 2017
-
$33.54 M(+12.4%)
$120.94 M(+5.7%)
Mar 2017
-
$29.84 M(+1.7%)
$114.38 M(+0.0%)
Dec 2016
$114.32 M(-39.4%)
$29.35 M(+4.0%)
$114.32 M(-1.2%)
Sep 2016
-
$28.21 M(+4.6%)
$115.67 M(-18.1%)
Jun 2016
-
$26.98 M(-9.4%)
$141.19 M(-16.5%)
Mar 2016
-
$29.79 M(-3.0%)
$169.03 M(-10.3%)
Dec 2015
$188.53 M(-49.5%)
$30.69 M(-42.9%)
$188.53 M(-26.1%)
Sep 2015
-
$53.73 M(-2.0%)
$255.18 M(-14.2%)
Jun 2015
-
$54.82 M(+11.2%)
$297.42 M(-10.7%)
Mar 2015
-
$49.28 M(-49.4%)
$333.05 M(-10.8%)
Dec 2014
$373.23 M(+4.0%)
$97.35 M(+1.4%)
$373.23 M(+0.7%)
Sep 2014
-
$95.97 M(+6.1%)
$370.52 M(+1.3%)
Jun 2014
-
$90.45 M(+1.1%)
$365.91 M(+0.7%)
Mar 2014
-
$89.46 M(-5.5%)
$363.29 M(+1.2%)
Dec 2013
$358.89 M(+12.1%)
$94.65 M(+3.6%)
$358.89 M(+3.8%)
Sep 2013
-
$91.35 M(+4.0%)
$345.61 M(+2.8%)
Jun 2013
-
$87.83 M(+3.3%)
$336.10 M(+3.3%)
Mar 2013
-
$85.06 M(+4.5%)
$325.47 M(+1.6%)
Dec 2012
$320.20 M(+17.3%)
$81.37 M(-0.6%)
$320.20 M(+0.8%)
Sep 2012
-
$81.84 M(+6.0%)
$317.51 M(+4.1%)
Jun 2012
-
$77.20 M(-3.2%)
$304.94 M(+4.7%)
Mar 2012
-
$79.79 M(+1.4%)
$291.13 M(+6.6%)
Dec 2011
$273.05 M(+10.1%)
$78.67 M(+13.6%)
$273.05 M(+4.8%)
Sep 2011
-
$69.27 M(+9.3%)
$260.46 M(+1.5%)
Jun 2011
-
$63.40 M(+2.8%)
$256.55 M(+1.5%)
Mar 2011
-
$61.70 M(-6.6%)
$252.63 M(+1.8%)
Dec 2010
$248.10 M(+17.7%)
$66.09 M(+1.1%)
$248.10 M(+6.7%)
Sep 2010
-
$65.36 M(+9.9%)
$232.61 M(+7.0%)
Jun 2010
-
$59.49 M(+4.1%)
$217.48 M(+0.9%)
Mar 2010
-
$57.17 M(+13.0%)
$215.58 M(+2.3%)
DateAnnualQuarterlyTTM
Dec 2009
$210.74 M(-10.6%)
$50.60 M(+0.8%)
$210.80 M(-6.5%)
Sep 2009
-
$50.22 M(-12.8%)
$225.45 M(-4.4%)
Jun 2009
-
$57.59 M(+9.9%)
$235.86 M(-1.2%)
Mar 2009
-
$52.38 M(-19.7%)
$238.64 M(+1.2%)
Dec 2008
$235.68 M(+15.9%)
$65.25 M(+7.6%)
$235.86 M(+0.4%)
Sep 2008
-
$60.63 M(+0.4%)
$234.85 M(+4.1%)
Jun 2008
-
$60.37 M(+21.7%)
$225.57 M(+6.2%)
Mar 2008
-
$49.61 M(-22.8%)
$212.37 M(+3.8%)
Dec 2007
$203.32 M(+43.9%)
$64.24 M(+25.1%)
$204.68 M(+12.4%)
Sep 2007
-
$51.35 M(+8.9%)
$182.08 M(+7.7%)
Jun 2007
-
$47.16 M(+12.5%)
$169.06 M(+7.6%)
Mar 2007
-
$41.92 M(+0.7%)
$157.17 M(+9.3%)
Dec 2006
$141.25 M(+81.1%)
$41.64 M(+8.6%)
$143.79 M(+16.7%)
Sep 2006
-
$38.34 M(+8.7%)
$123.25 M(+19.5%)
Jun 2006
-
$35.27 M(+23.6%)
$103.17 M(+16.3%)
Mar 2006
-
$28.54 M(+35.3%)
$88.73 M(+13.8%)
Dec 2005
$77.99 M(+22.0%)
$21.09 M(+15.5%)
$77.99 M(+2.1%)
Sep 2005
-
$18.26 M(-12.3%)
$76.36 M(+1.2%)
Jun 2005
-
$20.83 M(+17.0%)
$75.45 M(+11.5%)
Mar 2005
-
$17.81 M(-8.5%)
$67.67 M(+5.6%)
Dec 2004
$63.91 M(+13.8%)
$19.46 M(+12.1%)
$64.11 M(+1.7%)
Sep 2004
-
$17.36 M(+33.0%)
$63.05 M(+0.5%)
Jun 2004
-
$13.05 M(-8.4%)
$62.72 M(+0.6%)
Mar 2004
-
$14.24 M(-22.6%)
$62.32 M(+10.7%)
Dec 2003
$56.16 M(+38.6%)
$18.40 M(+8.0%)
$56.31 M(+14.2%)
Sep 2003
-
$17.03 M(+34.6%)
$49.30 M(+8.7%)
Jun 2003
-
$12.65 M(+53.7%)
$45.34 M(+1.3%)
Mar 2003
-
$8.23 M(-27.7%)
$44.76 M(-6.7%)
Dec 2002
$40.52 M(-34.7%)
$11.39 M(-12.8%)
$47.99 M(+7.5%)
Sep 2002
-
$13.07 M(+8.2%)
$44.63 M(-14.1%)
Jun 2002
-
$12.07 M(+5.3%)
$51.95 M(-9.3%)
Mar 2002
-
$11.46 M(+42.7%)
$57.30 M(-7.8%)
Dec 2001
$62.09 M(+15.5%)
$8.03 M(-60.6%)
$62.13 M(-12.8%)
Sep 2001
-
$20.39 M(+17.1%)
$71.21 M(+8.7%)
Jun 2001
-
$17.42 M(+7.0%)
$65.48 M(+8.8%)
Mar 2001
-
$16.29 M(-4.8%)
$60.16 M(+11.5%)
Dec 2000
$53.75 M(+37.3%)
$17.11 M(+16.6%)
$53.95 M(+21.5%)
Sep 2000
-
$14.67 M(+21.2%)
$44.41 M(-1.6%)
Jun 2000
-
$12.10 M(+20.1%)
$45.11 M(+5.8%)
Mar 2000
-
$10.08 M(+33.3%)
$42.64 M(+9.4%)
Dec 1999
$39.16 M(-31.3%)
$7.56 M(-50.8%)
$38.99 M(-12.7%)
Sep 1999
-
$15.37 M(+59.6%)
$44.64 M(-9.4%)
Jun 1999
-
$9.63 M(+49.8%)
$49.27 M(-8.0%)
Mar 1999
-
$6.43 M(-51.3%)
$53.54 M(-6.4%)
Dec 1998
$57.01 M(+36.7%)
$13.21 M(-33.9%)
$57.21 M(-5.4%)
Sep 1998
-
$20.00 M(+43.9%)
$60.50 M(+16.1%)
Jun 1998
-
$13.90 M(+37.6%)
$52.10 M(+9.9%)
Mar 1998
-
$10.10 M(-38.8%)
$47.40 M(+13.1%)
Dec 1997
$41.70 M(+143.9%)
$16.50 M(+42.2%)
$41.90 M(+39.7%)
Sep 1997
-
$11.60 M(+26.1%)
$30.00 M(+29.3%)
Jun 1997
-
$9.20 M(+100.0%)
$23.20 M(+28.2%)
Mar 1997
-
$4.60 M(0.0%)
$18.10 M(+4.0%)
Dec 1996
$17.10 M(+29.5%)
$4.60 M(-4.2%)
$17.40 M(+6.7%)
Sep 1996
-
$4.80 M(+17.1%)
$16.30 M(+9.4%)
Jun 1996
-
$4.10 M(+5.1%)
$14.90 M(-49.3%)
Mar 1996
-
$3.90 M(+11.4%)
$29.40 M(-32.1%)
Dec 1995
$13.20 M
$3.50 M(+2.9%)
$43.30 M(+8.8%)
Sep 1995
-
$3.40 M(-81.7%)
$39.80 M(+9.3%)
Jun 1995
-
$18.60 M(+4.5%)
$36.40 M(+104.5%)
Mar 1995
-
$17.80 M
$17.80 M

FAQ

  • What is Core Laboratories NV annual EBITDA?
  • What is the all time high annual EBITDA for Core Laboratories NV?
  • What is Core Laboratories NV annual EBITDA year-on-year change?
  • What is Core Laboratories NV quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Core Laboratories NV?
  • What is Core Laboratories NV quarterly EBITDA year-on-year change?
  • What is Core Laboratories NV TTM EBITDA?
  • What is the all time high TTM EBITDA for Core Laboratories NV?
  • What is Core Laboratories NV TTM EBITDA year-on-year change?

What is Core Laboratories NV annual EBITDA?

The current annual EBITDA of CLB is $73.51 M

What is the all time high annual EBITDA for Core Laboratories NV?

Core Laboratories NV all-time high annual EBITDA is $373.23 M

What is Core Laboratories NV annual EBITDA year-on-year change?

Over the past year, CLB annual EBITDA has changed by +$3.08 M (+4.38%)

What is Core Laboratories NV quarterly EBITDA?

The current quarterly EBITDA of CLB is $17.84 M

What is the all time high quarterly EBITDA for Core Laboratories NV?

Core Laboratories NV all-time high quarterly EBITDA is $97.35 M

What is Core Laboratories NV quarterly EBITDA year-on-year change?

Over the past year, CLB quarterly EBITDA has changed by -$617.00 K (-3.34%)

What is Core Laboratories NV TTM EBITDA?

The current TTM EBITDA of CLB is $73.51 M

What is the all time high TTM EBITDA for Core Laboratories NV?

Core Laboratories NV all-time high TTM EBITDA is $373.23 M

What is Core Laboratories NV TTM EBITDA year-on-year change?

Over the past year, CLB TTM EBITDA has changed by +$3.08 M (+4.38%)